Stay updated with breaking news from Repligen Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Repligen Co. (NASDAQ:RGEN – Get Free Report) Director Karen A. Dawes sold 850 shares of the firm’s stock in a transaction dated Tuesday, August 29th. The stock was sold at an average price of $171.38, for a total value of $145,673.00. Following the transaction, the director now directly owns 83,741 shares in the company, valued […]
Skandinaviska Enskilda Banken AB publ lowered its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 1.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,556 shares of the biotechnology company’s stock after selling 123 shares during […]
Swiss National Bank lessened its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 2.4% in the 1st quarter, HoldingsChannel.com reports. The firm owned 208,900 shares of the biotechnology company’s stock after selling 5,200 shares during the period. Swiss National Bank’s holdings in Repligen were worth $35,170,000 as of its most recent filing […]
Bessemer Group Inc. lifted its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 1.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 285,114 shares of the biotechnology company’s stock after acquiring an additional 4,098 shares during the […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.